Braiin
BRAI
4.51
-0.20
-4.25%
Braiin
US · BRAI
#3295 by market cap
Listed 2026
4.51
-0.20
-4.25%
Live - 5344 symbols - heartbeat 301s ago
· 2026-10-08 07:27
Pre-market
4.50
-0.22%
After-hours
4.71
+4.43%
- Market cap
- 929.46M
- P/E (TTM)i
- -32.21
- P/Bi
- 4.15
- EPSi
- -0.14
- Div yieldi
- 0.00%
- 52W posi
- 1%
Reader sentiment
Are you bullish or bearish on BRAI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 8.40, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 3 years
Margins
- Gross margin
- 31.59%
- Operating margin
- -29.97%
- Net margin
- -39.31%
Key ratios & quality
- Enterprise valuei
- 928.43M
- Altman Z-Scorei
- 8.40
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 0 | 0 | 73.41M |
| Gross profit | -- | -- | 23.19M |
| Selling & admin expenses | 675.69K | 1.29M | 35.05M |
| Research & development | -- | -- | -- |
| Operating profit | -759.14K | -1.44M | -22.00M |
| Pretax profit | -778.01K | -1.72M | -27.99M |
| Tax | 0 | 0 | 868.00K |
| Net profit | -778.01K | -1.72M | -28.86M |
| Basic EPS | 0 | 0 | 0 |
| Diluted EPS | 0.00 | -0.01 | -0.14 |
| Line item | 2024-06 | 2024-12 | 2025-06 |
|---|---|---|---|
| Revenue | -- | -- | -- |
| Gross profit | -- | -- | -- |
| Selling & admin expenses | -- | -- | -- |
| Research & development | -- | -- | -- |
| Operating profit | -- | -- | -- |
| Pretax profit | -- | -- | -- |
| Tax | -- | -- | -- |
| Net profit | -- | -- | -- |
| Basic EPS | -- | -- | -- |
| Diluted EPS | -- | -- | -- |
Balance sheet
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total current assets | 1.25M | 704.93K | 39.24M |
| Cash & ST investments | 1.20M | 577.52K | 4.28M |
| Inventory | -- | -- | 3.21M |
| Total assets | 1.54M | 844.85K | 290.28M |
| Total current liabilities | 2.69M | 3.67M | 24.78M |
| Short-term debt | 284.99K | 754.75K | 51.00K |
| Long-term debt | 81.51K | -- | 3.21M |
| Total liabilities | 2,672,229.00 | 3,671,056.00 | 65,978,000.00 |
| Total equity | -1.13M | -2.83M | 224.31M |
| Retained earnings | -1.14M | -2.85M | -23.05M |
| Line item | 2024-06 | 2024-12 | 2025-06 |
|---|---|---|---|
| Total current assets | 704.93K | 32.28M | 39.24M |
| Cash & ST investments | 577.52K | 3.69M | 4.28M |
| Inventory | -- | 3.77M | 3.21M |
| Total assets | 844.85K | 282.97M | 290.28M |
| Total current liabilities | 3.67M | 21.20M | 24.78M |
| Short-term debt | 754.75K | 102.00K | 51.00K |
| Long-term debt | -- | 3.38M | 3.21M |
| Total liabilities | 3,671,056.00 | 54,518,000.00 | 65,978,000.00 |
| Total equity | -2.83M | 228.45M | 224.31M |
| Retained earnings | -2.85M | -7.12M | -23.05M |
Cash flow
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating cash flow | -- | -- | -- |
| Depreciation & amortization | -- | -- | -- |
| Free cash flow | -612.52K | -707.76K | -1.18M |
| Dividends paid | -- | 0 | 0 |
| Stock buybacks / issuance | 641 | -- | -- |
| Ending cash balance | 1.20M | 577.52K | 110.78K |
| Line item | 2024-06 | 2024-12 | 2025-06 |
|---|---|---|---|
| Operating cash flow | -- | -- | -- |
| Depreciation & amortization | -- | -- | -- |
| Free cash flow | -- | -- | -- |
| Dividends paid | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- |
| Ending cash balance | -- | -- | -- |
Returns & efficiency
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| ROE %i | -- | -- | -26.06 |
| ROA %i | -50.47 | -286.30 | -19.83 |
| ROIC %i | -- | -- | -23.94 |
| 5-year avg ROE %i | -- | -- | -- |
| EBIT margin %i | -- | -1.32 | -34.54 |
| FCF / sales %i | -- | -- | -- |
| Current ratioi | 0.47 | 0.19 | 1.58 |
| Quick ratioi | 0.46 | 0.19 | 0.96 |
| Debt / assetsi | 23.88 | 89.34 | 1.18 |
| LT debt / equityi | -- | -- | 1.51 |
| Interest coveragei | -96.58 | -1.04 | -9.61 |
| Revenue CAGR (3Y) %i | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- |
| Line item | 2024-06 | 2024-12 | 2025-06 |
|---|---|---|---|
| ROE %i | -- | -1.70 | -26.06 |
| ROA %i | -286.30 | -1.37 | -19.83 |
| ROIC %i | -- | -1.29 | -23.94 |
| 5-year avg ROE %i | -- | -- | -- |
| EBIT margin %i | -1.32 | -0.35 | -34.54 |
| FCF / sales %i | -- | -- | -- |
| Current ratioi | 0.19 | 1.52 | 1.58 |
| Quick ratioi | 0.19 | 0.76 | 0.96 |
| Debt / assetsi | 89.34 | 1.29 | 1.18 |
| LT debt / equityi | -- | 1.55 | 1.51 |
| Interest coveragei | -1.04 | -0.29 | -9.61 |
| Revenue CAGR (3Y) %i | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- |
Quote time 2026-10-08 07:27:47 · For reference only, not investment advice and not tailored to your situation.